Initiator Pharma: Full focus on pudafensine, IP2018 is discontinued

About this update from Initiator Pharma A/s

Redeye’s analyst just published a Research Note on Initiator Pharma.Click here to read the articleMake sure to add Initiator Pharma to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.This is a press release from Redeye - Research Powered Investment Banking. www.redeye.seAttachments

View stock analysis, news, and events for Initiator Pharma A/s